{"id":186077,"date":"2025-01-31T09:13:04","date_gmt":"2025-01-31T06:13:04","guid":{"rendered":"https:\/\/www.sancakhaber.com\/?p=186077"},"modified":"2025-01-31T09:19:53","modified_gmt":"2025-01-31T06:19:53","slug":"cocukluk-cagi-kanserleri","status":"publish","type":"post","link":"https:\/\/www.sancakhaber.com\/yedek\/cocukluk-cagi-kanserleri.html\/","title":{"rendered":"\u00c7OCUKLUK \u00c7A\u011eI KANSERLER\u0130 NASIL FARK ED\u0130L\u0130R?"},"content":{"rendered":"<h2><b>\u00c7ocukluk \u00e7a\u011f\u0131 kanserlerinde l\u00f6semi ba\u015f\u0131 \u00e7ekiyor<\/b><\/h2>\n<p>\u00c7ocuklarda kanser eri\u015fkinlere oranla 100 kat daha az g\u00f6r\u00fcl\u00fcr. T\u00fcrkiye\u2019de ve d\u00fcnyada her 1 milyon \u00e7ocuktan 110-150\u2019sinde kansere rastlan\u0131yor. Hastal\u0131\u011fa dikkat \u00e7eken\u00a0 <a href=\"https:\/\/saglikbul.com.tr\/uzm-dr-burcak-kurucu-kimdir\/\">\u00c7ocuk Hematolojisi ve Onkolojisi<\/a> Uzman\u0131 Prof. Dr. T\u00fclin Tiraje Celkan, t\u00fcm kanserlerin sadece y\u00fczde 2-4\u2019\u00fcn\u00fcn \u00e7ocuklarda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirterek, \u201cHer y\u0131l 1 milyon \u00e7ocuktan 110-150\u2019sinde kanser geli\u015fiyor. BU hastal\u0131kta en s\u0131k ilk 5 ya\u015fta ve 10-15 ya\u015f d\u00f6neminde ortaya \u00e7\u0131k\u0131yor. Tedavi ba\u015far\u0131s\u0131n\u0131n y\u00fcksek olmas\u0131 ve \u00e7ocuklar\u0131n \u00f6n\u00fcndeki beklenen ya\u015fam s\u00fcresinin uzunlu\u011fu, erken tan\u0131 ve tedavinin \u00f6nemini ortaya koyuyor. Geli\u015fmi\u015f \u00fclkelerde \u00e7ocuklar aras\u0131nda en s\u0131k \u00f6l\u00fcm nedenlerinde 2\u2019nci s\u0131rada olan kanserler, \u00fclkemizde enfeksiyonlar, kazalar, kalp hastal\u0131klar\u0131ndan sonra 4\u2019\u00fcnc\u00fc s\u0131rada yer al\u0131yor. N\u00fcfusumuzun y\u00fczde 26,3\u2019\u00fc 0-14 ya\u015f aras\u0131nda bulunuyor. \u00dclke n\u00fcfusumuzu 84 milyon olarak kabul edersek 21 milyon \u00e7ocuk i\u00e7in y\u0131ll\u0131k beklenen yeni kanserli \u00e7ocuk olgu say\u0131s\u0131 2 bin 500 ile 3 bin aras\u0131ndad\u0131r\u201d dedi.<\/p>\n<h2><b>\u00c7OCU\u011eUNUZUN DER\u0130S\u0130NDE NOKTA KANAMALAR, MORLUKLAR, HALS\u0130ZL\u0130K, YORGUNLUK, KEM\u0130K A\u011eRISI VARSA D\u0130KKAT<\/b><\/h2>\n<p>T\u00fcrkiye\u2019de ve d\u00fcnyada \u00e7ocukluk \u00e7a\u011f\u0131nda g\u00f6r\u00fclen kanserlerin y\u00fczde 30\u2019unu l\u00f6semi olu\u015fturuyor. \u00dclkemizde ikinci s\u0131rada lenf bezi kanserleri (Hodgkin ve Hodgkin-d\u0131\u015f\u0131 lenfoma) yer al\u0131yor. Bunlar\u0131 s\u0131ras\u0131yla <a href=\"https:\/\/www.sancakhaber.com\/canli-ameliyat-esliginde-kapali-fitik-cerrahi-egitimi-yapildi.html\/\">sinir sistemi t\u00fcm\u00f6rleri, n\u00f6roblastoma<\/a>, Wilms t\u00fcm\u00f6r\u00fc ve yumu\u015fak doku sarkomalar\u0131 (rabdomiyosarkoma) izliyor. Kemik, deri, g\u00f6z ve karaci\u011fer t\u00fcm\u00f6rleri ise \u00e7ocuklarda daha nadirdir.\u00a0 T\u00fcm\u00f6rlerin \u00e7o\u011fu embriyonel kaynakl\u0131, eri\u015fkin kanserlerinin \u00e7o\u011fu ise karsinomlard\u0131r. Genetik nedenler, eri\u015fkin kanserlerinden \u00e7ok daha s\u0131k saptan\u0131yor. Ailevi yatk\u0131nl\u0131k, do\u011fumsal hastal\u0131klar, do\u011fumsal anomaliler, gen bozukluklar\u0131, imm\u00fcn yetmezlikler ve n\u00f6rofibromatozis gibi genetik hastal\u0131klar kansere yatk\u0131nl\u0131k yarat\u0131yor.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-186080\" src=\"https:\/\/www.sancakhaber.com\/wp-content\/uploads\/2025\/01\/Prof.-Dr.-Tulin-Tiraje-Celkan-300x300.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/Prof.-Dr.-Tulin-Tiraje-Celkan-300x300.jpg 300w, https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/Prof.-Dr.-Tulin-Tiraje-Celkan-150x150.jpg 150w, https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/Prof.-Dr.-Tulin-Tiraje-Celkan.jpg 320w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><b>\u0130yile\u015fme oranlar\u0131 y\u00fczde 5\u2019ten 80\u2019e \u00e7\u0131kt\u0131<\/b><\/p>\n<p>\u00c7ocuk kanserlerinin \u00f6zelliklerinden biri, \u00e7ok h\u0131zl\u0131 \u00e7o\u011falan ve b\u00fcy\u00fcyen kanserler olmalar\u0131d\u0131r. H\u0131zl\u0131 b\u00fcy\u00fcd\u00fckleri i\u00e7in de ila\u00e7 tedavisi (kemoterapi) ve \u0131\u015f\u0131n tedavisine (radyoterapi) duyarl\u0131 oluyorlar. \u00c7ocuk kanserlerinde genellikle cerrahi, \u0131\u015f\u0131n ve ila\u00e7 tedavileri birlikte kullan\u0131l\u0131yor. I\u015f\u0131n ge\u00e7 yan etkileri fazla oldu\u011fu i\u00e7in giderek \u00e7ocukluk \u00e7a\u011f\u0131 kanser tedavilerinde daha az s\u0131kl\u0131kla ve azalan doz ve s\u00fcreler ile yer al\u0131yor. Genellikle tedavinin kesilmesinden sonra 5 y\u0131l ge\u00e7mi\u015f ve kanser tekrarlamam\u0131\u015fsa hasta tamamen k\u00fcr olmu\u015f deniliyor. 1960\u2019l\u0131 y\u0131llarda y\u00fczde 5\u2019i iyile\u015fen \u00e7ocukluk \u00e7a\u011f\u0131 l\u00f6semilerinin g\u00fcn\u00fcm\u00fczde y\u00fczde 75-80\u2019i \u015fifa buluyor.<\/p>\n<p><b>Hangi belirtilerde \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinden \u015f\u00fcphelenilmeli?<\/b><\/p>\n<ul>\n<li>\u00c7ocukta beze, kans\u0131zl\u0131k, kar\u0131n \u015fi\u015fli\u011fi, herhangi bir dokuda anormal bir b\u00fcy\u00fcme fark edildi\u011finde derhal hekime ba\u015fvurmal\u0131 ve nedeni ara\u015ft\u0131r\u0131lmal\u0131d\u0131r.<\/li>\n<li>Hastada solukluk, deride nokta kanamalar veya morluklar, halsizlik, yorgunluk, kemik a\u011fr\u0131s\u0131 gibi belirtiler varsa; dala\u011f\u0131 ve karaci\u011feri, bezeleri b\u00fcy\u00fcm\u00fc\u015fse akla \u00f6ncelikle l\u00f6semi gelmelidir. Bu durumda hemen bir kan tetkiki ve kesin tan\u0131 i\u00e7in gerekiyorsa kemik ili\u011fi tetkiki yap\u0131l\u0131r. Lenf bezi b\u00fcy\u00fcmelerine ate\u015f, gece terlemeleri, halsizlik, kilo kayb\u0131, ka\u015f\u0131nt\u0131 gibi belirtiler e\u015flik ediyorsa, Hodgkin hastal\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fclmelidir. Tan\u0131ya, lenf bezinden biyopsi yap\u0131larak gidilir.<\/li>\n<li>K\u00fc\u00e7\u00fck \u00e7ocuklarda a\u011fr\u0131s\u0131z bir kar\u0131n kitlesi, deri alt\u0131nda k\u00fc\u00e7\u00fck \u015fi\u015flikler (nod\u00fcl), \u00f6ks\u00fcr\u00fck veya ate\u015f, solukluk, g\u00f6zlerin tek veya \u00e7ift tarafl\u0131 \u00f6ne f\u0131rlamas\u0131 ve g\u00f6z \u00e7evresinde morluk gibi belirtiler, kemik a\u011fr\u0131lar\u0131 varsa \u201cn\u00f6roblastoma\u201d ad\u0131 verilen b\u00f6brek\u00fcst\u00fc bezinden veya sempatik sinir sisteminden kaynaklanan bir t\u00fcm\u00f6r akla gelir. Tan\u0131ya biyopsi veya kemik ili\u011fi tetkiki, t\u00fcm\u00f6r belirte\u00e7leri (NSE testi) ile gidilir.<\/li>\n<li>A\u011fr\u0131s\u0131z kar\u0131n kitlesi veya nadiren kar\u0131n a\u011fr\u0131s\u0131 ve kar\u0131nda \u015fi\u015flik, idrarda kan, g\u00f6z\u00fcn renkli tabakas\u0131 irisin yoklu\u011fu gibi belirtiler k\u00fc\u00e7\u00fck bir \u00e7ocukta b\u00f6brek t\u00fcm\u00f6r\u00fcn\u00fc (Wilms t\u00fcm\u00f6r\u00fc) d\u00fc\u015f\u00fcnd\u00fcrmelidir. Tan\u0131, g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleri (MR veya BT) ve biyopsi ile konur.<\/li>\n<li>Karaci\u011fer b\u00f6lgesinde \u015fi\u015flik, sar\u0131l\u0131k, bulant\u0131, kusma, kilo kayb\u0131 gibi belirtiler ise karaci\u011fer t\u00fcm\u00f6r\u00fcn\u00fc akla getirmelidir. Bu durumda kanda alfa-fetoprotein (ALP) denen t\u00fcm\u00f6r belirteci y\u00fckselmi\u015f olarak saptanacakt\u0131r. Tan\u0131 biyopsi ile konur.<\/li>\n<li><\/li>\n<li><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-186079\" src=\"https:\/\/www.sancakhaber.com\/wp-content\/uploads\/2025\/01\/coculuk-cagi-kanserleri-1024x576.jpg\" alt=\"\u00e7ocukluk \u00e7a\u011f\u0131 kanserleri\" width=\"688\" height=\"387\" srcset=\"https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/coculuk-cagi-kanserleri-1024x576.jpg 1024w, https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/coculuk-cagi-kanserleri-300x169.jpg 300w, https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/coculuk-cagi-kanserleri-768x432.jpg 768w, https:\/\/www.sancakhaber.com\/yedek\/wp-content\/uploads\/2025\/01\/coculuk-cagi-kanserleri.jpg 1280w\" sizes=\"auto, (max-width: 688px) 100vw, 688px\" \/><\/li>\n<\/ul>\n<p><b>Tedavide farkl\u0131 y\u00f6ntemler uygulan\u0131yor<\/b><\/p>\n<p>\u00c7ocuk kanserlerinde cerrahi y\u00f6ntemler genellikle t\u00fcm\u00f6r kaynakland\u0131\u011f\u0131 organ i\u00e7inde s\u0131n\u0131rl\u0131 ise t\u00fcm\u00f6r\u00fcn \u00e7\u0131kar\u0131lmas\u0131 \u015feklindedir. Ancak t\u00fcm\u00f6r \u00e7\u0131kar\u0131lamayacak b\u00fcy\u00fckl\u00fckte ise veya ba\u015fka dokulara yay\u0131lma yapm\u0131\u015f ise (metastaz) bu durumda t\u00fcm\u00f6rden biyopsi almakla yetinilir ve \u00f6ncelikle kemoterapi uygulanarak t\u00fcm\u00f6r ve\/veya metastazlar\u0131 bu yol ile yok edilmeye \u00e7al\u0131\u015f\u0131l\u0131r. T\u00fcm\u00f6r k\u00fc\u00e7\u00fcl\u00fcp, metastazlar kaybolduktan sonra t\u00fcm\u00f6r kal\u0131nt\u0131s\u0131 cerrahi olarak \u00e7\u0131kar\u0131labilir.<\/p>\n<p>Kemoterapi, belirli aral\u0131klarla kemoterapi ila\u00e7lar\u0131n\u0131n a\u011f\u0131z veya damar yolu ile verilmesiyle yap\u0131l\u0131r. L\u00f6semi tedavisi s\u0131ras\u0131nda ila\u00e7lar beyin-omurilik s\u0131v\u0131s\u0131 i\u00e7ine de verilebilir; buna \u201cintratekal tedavi\u201d denir.<\/p>\n<p>Kemoterapi s\u00fcreleri, uygulanan tedavi \u015femalar\u0131na g\u00f6re farkl\u0131l\u0131klar g\u00f6sterir. 2-3 g\u00fcnden 7-8 g\u00fcne de\u011fi\u015fen s\u00fcrelerde, blok halinde genellikle 21-28 g\u00fcnde bir ila\u00e7lar\u0131n birlikte kullan\u0131m\u0131 s\u00f6z konusudur. Kemoterapinin s\u00fcresi genellikle 6 ay ile 2 y\u0131l aras\u0131nda de\u011fi\u015fir.<\/p>\n<p>Kemoterapide kullan\u0131lan ila\u00e7lar\u0131n baz\u0131 yan etkileri olur ancak bu etkilerin \u00e7o\u011fu ge\u00e7icidir ve birtak\u0131m ila\u00e7larla ba\u015far\u0131l\u0131 bir \u015fekilde \u00f6nlenebilir. Kemoterapi d\u00f6neminde \u00e7ocuk olduk\u00e7a halsiz olur, ayr\u0131ca bulant\u0131, kusma, kemik a\u011fr\u0131lar\u0131 g\u00f6r\u00fclebilir. Kemoterapinin d\u0131\u015ftan fark edilen en belirgin yan etkisi ise sa\u00e7lar\u0131n d\u00f6k\u00fclmesidir. Tedavileri biter bitmez sa\u00e7lar hemen \u00e7\u0131kmaya ba\u015flar.<\/p>\n<p>Kemoterapinin bir etkisi olarak enfeksiyon riski artt\u0131\u011f\u0131ndan bu d\u00f6nemde hijyen \u00e7ok \u00f6nem kazan\u0131r. Genellikle okul \u00e7a\u011f\u0131 \u00e7ocuklar\u0131n bir s\u00fcreli\u011fine okuldan uzak kalmas\u0131nda yarar vard\u0131r.<\/p>\n<p>Radyoterapi ise t\u00fcm\u00f6r\u00fcn bulundu\u011fu alana do\u011frudan \u0131\u015f\u0131n verilmesi \u015feklinde uygulanan tedavi \u015feklidir. Radyoterapi \u00e7ocuklarda m\u00fcmk\u00fcn oldu\u011fu kadar az kullan\u0131l\u0131r, \u00f6zellikle b\u00fcy\u00fcyen v\u00fccutlarda geli\u015fme bozukluklar\u0131na yol a\u00e7abilece\u011finden zorunlu durumlar d\u0131\u015f\u0131nda ilk tercih edilen tedavi de\u011fildir.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c7ocukluk \u00e7a\u011f\u0131 kanserlerinde l\u00f6semi ba\u015f\u0131 \u00e7ekiyor \u00c7ocuklarda kanser eri\u015fkinlere oranla 100 kat daha az g\u00f6r\u00fcl\u00fcr. T\u00fcrkiye\u2019de ve d\u00fcnyada her 1 milyon \u00e7ocuktan 110-150\u2019sinde kansere rastlan\u0131yor. Hastal\u0131\u011fa dikkat \u00e7eken\u00a0 \u00c7ocuk Hematolojisi ve Onkolojisi Uzman\u0131 Prof. Dr. T\u00fclin Tiraje Celkan, t\u00fcm kanserlerin sadece y\u00fczde 2-4\u2019\u00fcn\u00fcn \u00e7ocuklarda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirterek, \u201cHer y\u0131l 1 milyon \u00e7ocuktan 110-150\u2019sinde kanser geli\u015fiyor. BU [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":186078,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[402],"tags":[],"class_list":["post-186077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/posts\/186077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/comments?post=186077"}],"version-history":[{"count":0,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/posts\/186077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/media\/186078"}],"wp:attachment":[{"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/media?parent=186077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/categories?post=186077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sancakhaber.com\/yedek\/wp-json\/wp\/v2\/tags?post=186077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}